Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Iterum Therapeutics plc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +3 vs. Q2 2024
- Shares held
- 2.04M
- +1.61M (+372.9%) vs. Q2 2024
- Total value
- $2.22M
- +$1.73M (+349.6%) vs. Q2 2024
- New holders
- 8
- 1 more added
- Sold out
- 5
- 1 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $542 |
| Q1 2026 | 18 | $41.3K |
| Q4 2025 | 20 | $557.9K |
| Q3 2025 | 24 | $904.1K |
| Q2 2025 | 24 | $2.38M |
| Q1 2025 | 20 | $1.38M |
| Q4 2024 | 24 | $2.18M |
| Q3 2024 | 18 | $2.22M |
| Q2 2024 | 15 | $494.7K |
| Q1 2024 | 18 | $1.43M |
| Q4 2023 | 16 | $761.6K |
| Q3 2023 | 15 | $184.0K |
| Q2 2023 | 17 | $393.4K |
| Q1 2023 | 17 | $187.3K |
| Q4 2022 | 23 | $243.7K |
| Q3 2022 | 25 | $575.4K |
| Q2 2022 | 39 | $1.18M |
| Q1 2022 | 41 | $1.80M |
| Q4 2021 | 45 | $2.57M |
| Q3 2021 | 42 | $3.45M |
| Q2 2021 | 45 | $26.0M |
| Q1 2021 | 50 | $11.2M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Iterum Therapeutics plc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,340,000 | $1.46M | 0.04% | +1,340,000 | New |
| New Leaf Venture Partners, L.L.C. | 345,020 | $376.1K | 0.39% | +247,934+255.4% | Added |
| Apollon Financial, LLC | 224,750 | $245.0K | 0.07% | 00.0% | Unchanged |
| Alpine Global Management, LLC | 64,833 | $70.7K | 0.02% | +64,833 | New |
| XTX Topco Ltd | 33,040 | $36.0K | 0.00% | +33,040 | New |
| Two Sigma Securities, LLC | 14,947 | $16.3K | 0.00% | +14,947 | New |
| Geode Capital Management, LLC | 12,370 | $13.5K | 0.00% | +12,370 | New |
| Morgan Stanley | 5,479 | $5.97K | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 133 | $145 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 85 | $93 | 0.00% | −1,200−93.4% | Reduced |
| Blue Bell Private Wealth Management, LLC | 66 | $72 | 0.00% | 00.0% | Unchanged |
| Cypress Capital Management LLC (WY) | 66 | $72 | 0.00% | +66 | New |
| Planning Capital Management Corp | 40 | $44 | 0.00% | 00.0% | Unchanged |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 13 | $14 | 0.00% | +13 | New |
| HM Payson & Co | 3 | $4 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 2 | $2 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $1 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1 | $1 | 0.00% | +1 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −64,022−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −38,483−100.0% | Sold out |
| Kelly Financial Services LLC | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −12−100.0% | Sold out |